Catalyst Wire Dossier Catalyst Wire Dossier

SPIROMAX

budesonide/formoterol · Teva Branded Pharmaceutical Products R&D, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SPIROMAX, covering 2024-03-22 to 2024-03-22. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Participants With Asthma [Phase 3]

See pricing